Developer docs
API playgroundTry for free, no card

Search company profiles

Cytek Biosciences

Full company profile

uuid00007k4

Namestring
Cytek Biosciences
Legal namestring
Cytek Biosciences, Inc.
Websiteurl
cytekbio.com
Company typeenum
Public
Founded yearint
2014
Descriptiontext

Cytek Biosciences, Inc. (NASDAQ: CTKB) is a publicly traded life sciences tools company that designs, manufactures, and sells spectral flow cytometry instruments, reagents, software, and services for cell analysis. Founded in 2014 by Wenbin Jiang, Ph.D. (CEO) and Ming Yan, Ph.D. (CTO), the company is headquartered in Fremont, California, and operates 10 offices across the United States, Europe, and Asia-Pacific, including a manufacturing facility in Wuxi, China, a regional HQ in Amsterdam, and an APAC operations hub in Singapore.

The company's core technology is Full Spectrum Profiling (FSP), a proprietary spectral flow cytometry architecture that captures the entire emission signature of each fluorochrome across the light spectrum, enabling panels of up to 40+ colors (Aurora) and 60 colors (Borealis) without optical filter swaps. The instrument portfolio spans the high-end Cytek Borealis 7-laser system, Cytek Aurora Evo with 2X faster throughput and robotic plate handling integration, the Cytek Aurora CS cell sorter, mid-tier Cytek Aurora and Northern Lights systems (including the Northern Lights-CLC clinical variant), and compact analyzers such as Cytek Muse Micro and Guava easyCyte. Supporting offerings include Cytek Amnis ImageStreamX imaging flow cytometry (acquired from Luminex), the Cytek Orion automated reagent cocktail preparation system, cFluor and Tonbo reagent lines, SpectroFlo acquisition software, and the Cytek Cloud digital ecosystem (Panel Builder, SpectroPanel, Experiment Builder).

Cytek operates a hybrid razor-and-blade business model: capital-equipment instruments generate placement revenue, while recurring revenue (reagents, service contracts, software/cloud) reached 34% of total 2025 revenue and grew 21% YoY. Distribution combines direct field sales in 16 major-market countries with a global distributor network (including DKSH, Alliance Global, Biotecha, Aurogene, Gulf Scientific, and others), targeting pharmaceutical and biotech firms (14% YoY growth), academic and research institutions, contract research organizations, and clinical laboratories across more than 50 countries. Customer concentration risk is spread across thousands of instrument placements (3,664 base) with no single logo dominance, though the top three segments (pharma, academic, CRO) drive the bulk of revenue.

Short descriptiontext

Cytek Biosciences (NASDAQ: CTKB) develops and manufactures spectral flow cytometry instruments, reagents, and software for cell analysis, serving pharmaceutical and biotech firms, academic research institutions, CROs, and clinical laboratories globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersFremont, United States
HQ citystring
Fremont
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spectral flow cytometry, cell analysis instruments, flow cytometry reagents, immunophenotyping systems, cell sorting technology
Industry1 code
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Flow Cytometry Instruments
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Flow Cytometry Instruments
TypeHardware Sales
Description

Sale of spectral flow cytometers including Aurora, Aurora Evo, Borealis, Northern Lights, Aurora CS cell sorter, Guava, Muse systems. These are high-value capital equipment purchases with typically long sales cycles to academic and pharmaceutical customers.

biospace.com
2Reagents and Consumables
TypeSubscription Recurring
Description

Recurring revenue from cFluor reagents, reagent kits, and consumables. Reagent growth exceeded 20% in Q4 2025. New DUV and IR cFluor reagents launched for Borealis system with Early Access Program.

finance.yahoo.com
3Service and Support
TypeSubscription Recurring
Description

Recurring revenue from service contracts (Gold, Silver, Bronze plans) and support services. Service and reagent revenue expected to grow over 20% in 2026, representing 34% of total revenue with 21% year-over-year growth.

finance.yahoo.com
4Software Licenses and Cloud Platform
TypeSubscription Recurring
Description

Cytek Cloud platform licenses, SpectroFlo software licenses for instrument operation and data analysis.

cytekbio.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Gold Service Plan - Unlimited comprehensive coverage
ModelSubscriptionBilling cadenceAnnual
Notes

Unlimited coverage for parts, labor, and travel; 1 preventative maintenance visit per year; priority response time; unlimited phone and email support.

cytekbio.com
2Silver Service Plan - Limited repair coverage
ModelSubscriptionBilling cadenceAnnual
Notes

Limited coverage of parts, labor, and travel; 1 fully covered repair visit; 20% parts discount on subsequent repairs; preventative maintenance.

cytekbio.com
3Bronze Service Plan - Basic support
ModelSubscriptionBilling cadenceAnnual
Notes

10% parts discount; all other services billed at prevailing rate; preventative maintenance and technical support included.

cytekbio.com
4Volume-based reagent pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Automatic 20%-40% discount on reagent orders depending on order size. 'Power Your Experiments For Less' volume savings program for reagent purchases.

cytekbio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 18 records shown
1Cytek Aurora
Description

Full spectrum flow cytometry system with up to 5 lasers and 64 fluorescence detectors

cytekbio.com
+17 more records
Core offering1 text field

Cytek Biosciences designs, manufactures, and globally distributes full spectrum flow cytometry instruments (Aurora, Aurora Evo, Aurora CS, Borealis, Northern Lights, Northern Lights-CLC, Amnis ImageStreamX, Muse Micro, Guava Muse, Guava easyCyte), proprietary cFluor and Tonbo reagents, the Orion automated reagent cocktail system, SpectroFlo acquisition software, and the Cytek Cloud digital ecosystem. The company also delivers Design-In panel development services and tiered service plans (Gold, Silver, Bronze) to pharmaceutical, biotech, CRO, academic, and clinical laboratory customers in the US, Europe, Japan, China, and Asia-Pacific.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Outperformed declining flow cytometry market with 1% revenue growth vs 4% market decline, demonstrating market share gains
+3 more records
Product overview1 text field

Cytek Biosciences offers a comprehensive cell analysis solutions portfolio centered on Full Spectrum Profiling (FSP) technology. The core instrument lineup includes the Cytek Borealis (next-generation 7-laser system), Cytek Aurora Evo and Cytek Aurora (high-performance spectral analyzers), Cytek Aurora CS (cell sorter), Cytek Northern Lights (research) and Northern Lights-CLC (clinical), and compact options (Muse Micro, Guava Muse, Guava easyCyte). The portfolio extends to the Cytek Amnis ImageStreamX for imaging capabilities. Supporting products include the Cytek Orion automated reagent preparation system, cFluor and Tonbo reagents optimized for spectral cytometry, the Cytek Cloud platform with Panel Builder and SpectroPanel algorithm for automated panel design, and SpectroFlo acquisition software. The company provides Design-In services for pharmaceutical panel development and tiered service plans.

Product and service18 records
1Cytek Borealis
CategoryFlow Cytometry Instrument
Description

Next-generation 7-laser full spectrum flow cytometer with 120 detectors including Deep Ultraviolet and Infrared lasers, enabling up to 60-color panels with integrated spectral detection and cellular imaging capabilities.

2Cytek Aurora Evo
CategoryFlow Cytometry Instrument
Description

High-throughput spectral flow cytometer with sample flow rates up to 200 µL/min using both tubes and plates, featuring hardware harmonization for reproducible data across systems and up to 5 lasers with 64 fluorescence detectors.

3Cytek Aurora
CategoryFlow Cytometry Instrument
Description

Full spectrum flow cytometer with up to 5 lasers, 3 scattering channels, and 64 fluorescence detectors (365-829 nm range), capable of resolving up to 40 colors in combination for deep immunophenotyping.

4Cytek Aurora CS
CategoryFlow Cytometry Instrument - Cell Sorter
Description

Advanced spectral cell sorter sharing the same optical system as the Cytek Aurora analyzer, enabling assay transfer without panel modification, with sorting functionality up to 6 ways and index sorting capability.

5Cytek Northern Lights
CategoryFlow Cytometry Instrument
Description

Affordable full spectrum flow cytometry solution with 1-3 laser configurations, adaptable from 9-color to 24-color detection, featuring low cost of ownership with simplified setup between experiments.

6Cytek Northern Lights-CLC
CategoryFlow Cytometry Instrument - Clinical
Description

Clinical full spectrum flow cytometry system designed for clinical laboratories, maximizing operational efficiency with portable templates and reusable reference controls for day-to-day standardization.

7Cytek Orion
CategoryLaboratory Automation System
Description

Automated reagent cocktail preparation system delivering walk-away automation for preparing up to 60 antibody cocktails with speed, accuracy, and consistency while reducing hands-on time.

8Cytek Amnis ImageStreamX
CategoryImaging Flow Cytometry Instrument
Description

Flow cytometry system with imaging capabilities combining spectral detection with cellular imaging in a single system, acquired through Luminex ImageStream assets.

9Cytek Muse Micro
CategoryBenchtop Cell Analyzer
Description

Compact benchtop cell analyzer with up to 5-parameter analysis, featuring intuitive touchscreen interface and mix-and-read assays for accessible flow cytometry in smaller labs.

10Cytek Guava Muse
CategoryBenchtop Cell Analyzer
Description

Easy-to-use microcapillary cell analyzer with 3-parameter analysis in a compact benchtop format, making flow cytometry accessible with simplified workflows.

11Cytek Guava easyCyte
CategoryMicrocapillary Flow Cytometer
Description

Microcapillary flow cytometer with up to 3 lasers and 14 parameters, featuring microcapillary fluidics for direct absolute cell counting and walkaway automation for up to 96 samples.

12cFluor Reagents
CategoryFlow Cytometry Reagents
Description

Fluorochrome reagents optimized for spectral cytometry and full spectrum panels, including DUV and IR variants for expanded panel complexity.

13Tonbo Reagents
CategoryFlow Cytometry Reagents
Description

Quality flow cytometry reagents equivalent to top alternatives at exceptional value, including kits, viability dyes, and buffers.

14Cytek Cloud
CategoryLaboratory Software Platform
Description

Digital ecosystem for full spectrum flow cytometry research featuring Full Spectrum Viewer, Panel Builder with SpectroPanel automated design algorithm, and Experiment Builder for streamlined workflows.

15SpectroFlo
CategoryLaboratory Software
Description

Flow cytometry acquisition software for Cytek Aurora and Northern Lights platforms, featuring guided workflow from QC to data analysis with portable templates and reference controls.

16Design-In Services
CategoryProfessional Services
Description

Expert panel design, development, and validation services for pharmaceutical companies and CROs, including custom conjugation and CLSI-compliant validation.

17Service Plans
CategoryService Contract
Description

Tiered service contracts (Gold, Silver, Bronze) providing coverage for parts, labor, travel, preventative maintenance, and technical support.

18DxP Athena
CategoryConventional Flow Cytometer
Description

Conventional cytometry solution capable of measuring up to 13 fluorescence parameters.

Scale indicator20 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1International Society for Advancement of Cytometry (ISAC)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-30
Description

Cytek launched a two-part initiative with ISAC to expand access to flow cytometry worldwide. This includes awarding a three-laser Cytek Northern Lights flow cytometer and plans for a grant program to fund research projects. The collaboration aims to democratize research access and support scientific communities globally, including donation of an instrument to a hospital in Argentina.

biospace.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-02-13
Description

Cytek is acquiring the Flow Cytometry & Imaging business unit from Luminex Corporation, a subsidiary of DiaSorin. The acquisition includes over 7,000 instruments and ImageStream imaging capabilities. This transaction aligns with DiaSorin's strategic focus on core diagnostics operations while expanding Cytek's product offerings and geographic reach in cell analysis solutions. Transaction expected to close within 30 days from announcement.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

DKSH serves as a major distribution partner for Cytek covering multiple Asia-Pacific markets including Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and China. DKSH provides market expansion services supporting local sales and distribution of Cytek products in these regions.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Sapphire Bioscience distributes Cytek's reagent portfolio in their coverage region, providing local access to cFluor reagents and other consumables.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Cytek maintains a global distribution channel with numerous regional distributors covering Africa, Asia-Pacific, Europe, Latin America, and Middle East. Key distributors include Alliance Global (Africa), Abacus Dx, GEMATEC (Argentina), Separation Scientific (South Africa), DBR Biotech (Brazil), Biotecha (Baltic states), Accela (Czech), Aurogene (Italy), and many others covering specific geographic territories.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BD Biosciences (Becton Dickinson's life sciences arm) is the market-leading flow cytometry franchise with the FACSCelesta, FACSymphony, and FACSAria product lines. It is Cytek's most direct competitor, serving the same academic, pharma, and CRO customer base with both conventional and high-parameter flow cytometry.

TypeDirect peer
Description

Beckman Coulter Life Sciences (a Danaher operating company) offers the CytoFLEX, Navios, and DxFLEX flow cytometry platforms. It competes head-to-head with Cytek in research and clinical flow cytometry, and its broader Danaher backing provides distribution and reagent scale advantages.

TypeBroad incumbent
Description

Thermo Fisher sells the Attune NxT flow cytometer and a broad life sciences reagent and instrument portfolio. As a multi-billion-dollar life sciences conglomerate, it offers overlapping flow cytometry capabilities alongside much larger adjacent franchises, creating bundling pressure on Cytek.

4Sony Biotechnology
TypeDirect peer
Description

Sony Biotechnology produces the MA900 multi-application cell sorter and the SH800 cell sorter, both leveraging spectral detection. It is one of the closest direct competitors to Cytek in spectral/sorting flow cytometry for research and translational applications.

TypeDirect peer
Description

Miltenyi Biotec offers the MACSQuant flow cytometry platform alongside its magnetic cell separation and cell therapy workflow franchise. It overlaps with Cytek in flow-based cell analysis for immunology and cell therapy research and brings strong bundled reagent and consumable offerings.

TypeBroad incumbent
Description

Agilent offers the Novocyte flow cytometer line within its broader cell analysis and life sciences instrumentation portfolio. As a diversified instrumentation incumbent, it competes with Cytek across research and pharma customer workflows.

TypeEmerging player
Description

Standard BioTools markets the CyTOF mass cytometry platform for high-parameter single-cell analysis. It is an emerging, technology-differentiated alternative to spectral flow cytometry, competing for the same deep-immunophenotyping use cases as Cytek's FSP systems.

TypeEmerging player
Description

NanoCellect develops the WOLF and N1 cell sorters for gentle microfluidic cell sorting in genomics and antibody discovery. It targets overlapping research and biopharma applications with a gentler, smaller-footprint alternative to traditional flow sorters.

TypeBroad incumbent
Description

Becton Dickinson is the parent of BD Biosciences and a major diversified medical technology company. While broader than flow cytometry alone, its scale in reagents, service, and clinical channel relationships creates competitive pressure on Cytek, especially in regulated clinical markets.

TypeOthers
Description

10x Genomics provides single-cell sequencing platforms (Chromium) that overlap with flow cytometry in single-cell immune profiling and cell therapy development. It is adjacent rather than direct competition, but its tools increasingly substitute or complement high-parameter flow workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cytek Biosciences

Flow Cytometry Instrumentscytekbio.com

Cytek Biosciences (NASDAQ: CTKB) develops and manufactures spectral flow cytometry instruments, reagents, and software for cell analysis, serving pharmaceutical and biotech firms, academic research institutions, CROs, and clinical laboratories globally.

What Cytek Biosciences does

Cytek Biosciences, Inc. (NASDAQ: CTKB) is a publicly traded life sciences tools company that designs, manufactures, and sells spectral flow cytometry instruments, reagents, software, and services for cell analysis. Founded in 2014 by Wenbin Jiang, Ph.D. (CEO) and Ming Yan, Ph.D. (CTO), the company is headquartered in Fremont, California, and operates 10 offices across the United States, Europe, and Asia-Pacific, including a manufacturing facility in Wuxi, China, a regional HQ in Amsterdam, and an APAC operations hub in Singapore.

The company's core technology is Full Spectrum Profiling (FSP), a proprietary spectral flow cytometry architecture that captures the entire emission signature of each fluorochrome across the light spectrum, enabling panels of up to 40+ colors (Aurora) and 60 colors (Borealis) without optical filter swaps. The instrument portfolio spans the high-end Cytek Borealis 7-laser system, Cytek Aurora Evo with 2X faster throughput and robotic plate handling integration, the Cytek Aurora CS cell sorter, mid-tier Cytek Aurora and Northern Lights systems (including the Northern Lights-CLC clinical variant), and compact analyzers such as Cytek Muse Micro and Guava easyCyte. Supporting offerings include Cytek Amnis ImageStreamX imaging flow cytometry (acquired from Luminex), the Cytek Orion automated reagent cocktail preparation system, cFluor and Tonbo reagent lines, SpectroFlo acquisition software, and the Cytek Cloud digital ecosystem (Panel Builder, SpectroPanel, Experiment Builder).

Cytek operates a hybrid razor-and-blade business model: capital-equipment instruments generate placement revenue, while recurring revenue (reagents, service contracts, software/cloud) reached 34% of total 2025 revenue and grew 21% YoY. Distribution combines direct field sales in 16 major-market countries with a global distributor network (including DKSH, Alliance Global, Biotecha, Aurogene, Gulf Scientific, and others), targeting pharmaceutical and biotech firms (14% YoY growth), academic and research institutions, contract research organizations, and clinical laboratories across more than 50 countries. Customer concentration risk is spread across thousands of instrument placements (3,664 base) with no single logo dominance, though the top three segments (pharma, academic, CRO) drive the bulk of revenue.

Cytek Biosciences firmographics

Firmographics
Name
Cytek Biosciences
Legal name
Cytek Biosciences, Inc.
Website
https://cytekbio.com
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
251–500 employees
Short description
Cytek Biosciences (NASDAQ: CTKB) develops and manufactures spectral flow cytometry instruments, reagents, and software for cell analysis, serving pharmaceutical and biotech firms, academic research institutions, CROs, and clinical laboratories globally.
Ownership category
akta.pro rank

Cytek Biosciences industry classification

Industry
Product category
Flow Cytometry Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments

Keywords

  • Spectral flow cytometry
  • Cell analysis instruments
  • Flow cytometry reagents
  • Immunophenotyping systems
  • Cell sorting technology

Where Cytek Biosciences is headquartered

Location

Headquarters

HQ city
Fremont
HQ country
United States
HQ region
North America

Offices10 records

Markets served

Cytek Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Flow Cytometry Instruments: Sale of spectral flow cytometers including Aurora, Aurora Evo, Borealis, Northern Lights, Aurora CS cell sorter, Guava, Muse systems. These are high-value capital equipment purchases with typically long sales cycles to academic and pharmaceutical customers.
  2. Reagents and Consumables: Recurring revenue from cFluor reagents, reagent kits, and consumables. Reagent growth exceeded 20% in Q4 2025. New DUV and IR cFluor reagents launched for Borealis system with Early Access Program.
  3. Service and Support: Recurring revenue from service contracts (Gold, Silver, Bronze plans) and support services. Service and reagent revenue expected to grow over 20% in 2026, representing 34% of total revenue with 21% year-over-year growth.
  4. Software Licenses and Cloud Platform: Cytek Cloud platform licenses, SpectroFlo software licenses for instrument operation and data analysis.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualGold Service Plan - Unlimited comprehensive coverage
SubscriptionAnnualSilver Service Plan - Limited repair coverage
SubscriptionAnnualBronze Service Plan - Basic support
Unit PricingPay-as-you-goVolume-based reagent pricing

Go-to-market motion3 records

Distribution channels8 records

Marketing channels8 records

Cytek Biosciences product offering

Product offering

Core offering

Cytek Biosciences designs, manufactures, and globally distributes full spectrum flow cytometry instruments (Aurora, Aurora Evo, Aurora CS, Borealis, Northern Lights, Northern Lights-CLC, Amnis ImageStreamX, Muse Micro, Guava Muse, Guava easyCyte), proprietary cFluor and Tonbo reagents, the Orion automated reagent cocktail system, SpectroFlo acquisition software, and the Cytek Cloud digital ecosystem. The company also delivers Design-In panel development services and tiered service plans (Gold, Silver, Bronze) to pharmaceutical, biotech, CRO, academic, and clinical laboratory customers in the US, Europe, Japan, China, and Asia-Pacific.

Product overview

Cytek Biosciences offers a comprehensive cell analysis solutions portfolio centered on Full Spectrum Profiling (FSP) technology. The core instrument lineup includes the Cytek Borealis (next-generation 7-laser system), Cytek Aurora Evo and Cytek Aurora (high-performance spectral analyzers), Cytek Aurora CS (cell sorter), Cytek Northern Lights (research) and Northern Lights-CLC (clinical), and compact options (Muse Micro, Guava Muse, Guava easyCyte). The portfolio extends to the Cytek Amnis ImageStreamX for imaging capabilities. Supporting products include the Cytek Orion automated reagent preparation system, cFluor and Tonbo reagents optimized for spectral cytometry, the Cytek Cloud platform with Panel Builder and SpectroPanel algorithm for automated panel design, and SpectroFlo acquisition software. The company provides Design-In services for pharmaceutical panel development and tiered service plans.

Differentiator

Problem solved

Functional benefit

Brands

  • Cytek Aurora: Full spectrum flow cytometry system with up to 5 lasers and 64 fluorescence detectors
  • Cytek Aurora Evo
  • Cytek Aurora CS
  • Cytek Northern Lights
  • Cytek Northern Lights-CLC
  • Cytek Orion
  • Cytek Muse Micro
  • Cytek Guava
  • Cytek Amnis ImageStreamX
  • Cytek Borealis
  • DxP Athena
  • cFluor
  • SpectroFlo
  • Cytek Cloud
  • SpectroLearn
  • Tonbo
  • QbSure
  • ViaDye

Products and services

  • Cytek Borealis Next-generation 7-laser full spectrum flow cytometer with 120 detectors including Deep Ultraviolet and Infrared lasers, enabling up to 60-color panels with integrated spectral detection and cellular imaging capabilities.
  • Cytek Aurora Evo High-throughput spectral flow cytometer with sample flow rates up to 200 µL/min using both tubes and plates, featuring hardware harmonization for reproducible data across systems and up to 5 lasers with 64 fluorescence detectors.
  • Cytek Aurora Full spectrum flow cytometer with up to 5 lasers, 3 scattering channels, and 64 fluorescence detectors (365-829 nm range), capable of resolving up to 40 colors in combination for deep immunophenotyping.
  • Cytek Aurora CS Advanced spectral cell sorter sharing the same optical system as the Cytek Aurora analyzer, enabling assay transfer without panel modification, with sorting functionality up to 6 ways and index sorting capability.
  • Cytek Northern Lights Affordable full spectrum flow cytometry solution with 1-3 laser configurations, adaptable from 9-color to 24-color detection, featuring low cost of ownership with simplified setup between experiments.
  • Cytek Northern Lights-CLC Clinical full spectrum flow cytometry system designed for clinical laboratories, maximizing operational efficiency with portable templates and reusable reference controls for day-to-day standardization.
  • Cytek Orion Automated reagent cocktail preparation system delivering walk-away automation for preparing up to 60 antibody cocktails with speed, accuracy, and consistency while reducing hands-on time.
  • Cytek Amnis ImageStreamX Flow cytometry system with imaging capabilities combining spectral detection with cellular imaging in a single system, acquired through Luminex ImageStream assets.
  • Cytek Muse Micro Compact benchtop cell analyzer with up to 5-parameter analysis, featuring intuitive touchscreen interface and mix-and-read assays for accessible flow cytometry in smaller labs.
  • Cytek Guava Muse Easy-to-use microcapillary cell analyzer with 3-parameter analysis in a compact benchtop format, making flow cytometry accessible with simplified workflows.
  • Cytek Guava easyCyte Microcapillary flow cytometer with up to 3 lasers and 14 parameters, featuring microcapillary fluidics for direct absolute cell counting and walkaway automation for up to 96 samples.
  • cFluor Reagents Fluorochrome reagents optimized for spectral cytometry and full spectrum panels, including DUV and IR variants for expanded panel complexity.
  • Tonbo Reagents Quality flow cytometry reagents equivalent to top alternatives at exceptional value, including kits, viability dyes, and buffers.
  • Cytek Cloud Digital ecosystem for full spectrum flow cytometry research featuring Full Spectrum Viewer, Panel Builder with SpectroPanel automated design algorithm, and Experiment Builder for streamlined workflows.
  • SpectroFlo Flow cytometry acquisition software for Cytek Aurora and Northern Lights platforms, featuring guided workflow from QC to data analysis with portable templates and reference controls.
  • Design-In Services Expert panel design, development, and validation services for pharmaceutical companies and CROs, including custom conjugation and CLSI-compliant validation.
  • Service Plans Tiered service contracts (Gold, Silver, Bronze) providing coverage for parts, labor, travel, preventative maintenance, and technical support.
  • DxP Athena Conventional cytometry solution capable of measuring up to 13 fluorescence parameters.

Quantifiable outcome

  • Outperformed declining flow cytometry market with 1% revenue growth vs 4% market decline, demonstrating market share gains
  • +3 more outcomes

Companies that use Cytek Biosciences

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles5 records

Cytek Biosciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature10 records

Cytek Biosciences partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, major and minor.

  • International Society for Advancement of Cytometry (ISAC)coreStrategic or Co-development Partner · 30 October 2025Cytek launched a two-part initiative with ISAC to expand access to flow cytometry worldwide. This includes awarding a three-laser Cytek Northern Lights flow cytometer and plans for a grant program to fund research projects. The collaboration aims to democratize research access and support scientific communities globally, including donation of an instrument to a hospital in Argentina.
  • Luminex Corporation (DiaSorin subsidiary)coreStrategic or Co-development Partner · 13 February 2023Cytek is acquiring the Flow Cytometry & Imaging business unit from Luminex Corporation, a subsidiary of DiaSorin. The acquisition includes over 7,000 instruments and ImageStream imaging capabilities. This transaction aligns with DiaSorin's strategic focus on core diagnostics operations while expanding Cytek's product offerings and geographic reach in cell analysis solutions. Transaction expected to close within 30 days from announcement.
  • DKSH (Distribution Partner)majorChannel Partner/ Reseller/ DistributorDKSH serves as a major distribution partner for Cytek covering multiple Asia-Pacific markets including Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and China. DKSH provides market expansion services supporting local sales and distribution of Cytek products in these regions.
  • Sapphire BioscienceminorChannel Partner/ Reseller/ DistributorSapphire Bioscience distributes Cytek's reagent portfolio in their coverage region, providing local access to cFluor reagents and other consumables.
  • Global Distributor NetworkmajorChannel Partner/ Reseller/ DistributorCytek maintains a global distribution channel with numerous regional distributors covering Africa, Asia-Pacific, Europe, Latin America, and Middle East. Key distributors include Alliance Global (Africa), Abacus Dx, GEMATEC (Argentina), Separation Scientific (South Africa), DBR Biotech (Brazil), Biotecha (Baltic states), Accela (Czech), Aurogene (Italy), and many others covering specific geographic territories.

Scale indicators20 records

Recent moves6 records

Expansion highlights8 records

Cytek Biosciences competitors and assessment

Company assessment

Direct peers

  • BD Biosciences: BD Biosciences (Becton Dickinson's life sciences arm) is the market-leading flow cytometry franchise with the FACSCelesta, FACSymphony, and FACSAria product lines. It is Cytek's most direct competitor, serving the same academic, pharma, and CRO customer base with both conventional and high-parameter flow cytometry.
  • Beckman Coulter Life Sciences: Beckman Coulter Life Sciences (a Danaher operating company) offers the CytoFLEX, Navios, and DxFLEX flow cytometry platforms. It competes head-to-head with Cytek in research and clinical flow cytometry, and its broader Danaher backing provides distribution and reagent scale advantages.
  • Sony Biotechnology: Sony Biotechnology produces the MA900 multi-application cell sorter and the SH800 cell sorter, both leveraging spectral detection. It is one of the closest direct competitors to Cytek in spectral/sorting flow cytometry for research and translational applications.
  • Miltenyi Biotec: Miltenyi Biotec offers the MACSQuant flow cytometry platform alongside its magnetic cell separation and cell therapy workflow franchise. It overlaps with Cytek in flow-based cell analysis for immunology and cell therapy research and brings strong bundled reagent and consumable offerings.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher sells the Attune NxT flow cytometer and a broad life sciences reagent and instrument portfolio. As a multi-billion-dollar life sciences conglomerate, it offers overlapping flow cytometry capabilities alongside much larger adjacent franchises, creating bundling pressure on Cytek.
  • Agilent Technologies: Agilent offers the Novocyte flow cytometer line within its broader cell analysis and life sciences instrumentation portfolio. As a diversified instrumentation incumbent, it competes with Cytek across research and pharma customer workflows.
  • Becton, Dickinson and Company: Becton Dickinson is the parent of BD Biosciences and a major diversified medical technology company. While broader than flow cytometry alone, its scale in reagents, service, and clinical channel relationships creates competitive pressure on Cytek, especially in regulated clinical markets.

Emerging players

  • Standard BioTools (Fluidigm): Standard BioTools markets the CyTOF mass cytometry platform for high-parameter single-cell analysis. It is an emerging, technology-differentiated alternative to spectral flow cytometry, competing for the same deep-immunophenotyping use cases as Cytek's FSP systems.
  • NanoCellect Biomedical: NanoCellect develops the WOLF and N1 cell sorters for gentle microfluidic cell sorting in genomics and antibody discovery. It targets overlapping research and biopharma applications with a gentler, smaller-footprint alternative to traditional flow sorters.

Others

  • 10x Genomics: 10x Genomics provides single-cell sequencing platforms (Chromium) that overlap with flow cytometry in single-cell immune profiling and cell therapy development. It is adjacent rather than direct competition, but its tools increasingly substitute or complement high-parameter flow workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Cytek Biosciences social profiles

Digital presence

Cytek Biosciences compliance and trust

Trust signal

Compliance2 records

Cytek Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cytek Biosciences leadership team

Management profile

Number of profiles

Profiles10 records

Cytek Biosciences subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cytek Biosciences funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cytek Biosciences M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cytek Biosciences

What does Cytek Biosciences do?

Cytek Biosciences designs, manufactures, and globally distributes full spectrum flow cytometry instruments (Aurora, Aurora Evo, Aurora CS, Borealis, Northern Lights, Northern Lights-CLC, Amnis ImageStreamX, Muse Micro, Guava Muse, Guava easyCyte), proprietary cFluor and Tonbo reagents, the Orion automated reagent cocktail system, SpectroFlo acquisition software, and the Cytek Cloud digital ecosystem. The company also delivers Design-In panel development services and tiered service plans (Gold, Silver, Bronze) to pharmaceutical, biotech, CRO, academic, and clinical laboratory customers in the US, Europe, Japan, China, and Asia-Pacific.

Is Cytek Biosciences a public or private company?

Cytek Biosciences is a public company. It is classified as public and is currently operating.

When was Cytek Biosciences founded?

Cytek Biosciences was founded in 2014. It employs 251 to 500 people.

Where is Cytek Biosciences based?

Cytek Biosciences is headquartered in Fremont, United States, in the North America region.

How does Cytek Biosciences make money?

Four revenue lines are on record. Flow Cytometry Instruments are the primary driver. The others are reagents and Consumables, service and Support and software Licenses and Cloud Platform.

Who are Cytek Biosciences's main competitors?

Direct peers on record are BD Biosciences, Beckman Coulter Life Sciences, Sony Biotechnology and Miltenyi Biotec. Broad incumbents are Thermo Fisher Scientific, Agilent Technologies and Becton, Dickinson and Company. Emerging players are Standard BioTools (Fluidigm) and NanoCellect Biomedical. 10x Genomics is listed as an others.

Does Cytek Biosciences have an API?

No public API is recorded for Cytek Biosciences.

What industry is Cytek Biosciences in?

Cytek Biosciences's product category is Flow Cytometry Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StWhat Cytek Biosciences Holders Got RightCytek Biosciences shares rose 20.4% over the past year, trading at $5.79. Q3 2026 revenue was $53.229m, but net margin worsened to -11.5%. The stock's price assumes recurring revenue from an installed base can offset rising costs and regional weakness.Simply Wall StCytek Biosciences, Inc. (NASDAQ:CTKB) Analysts Are Pretty Bullish On The Stock After Recent ResultsCytek Biosciences reported Q2 revenue of $53m in line with expectations, but statutory losses of $0.05 per share were smaller than expected. Analysts now forecast 2027 revenue of $222.8m and losses of $0.25, with the average price target raised to $6.17. Revenue growth is expected to slow to 5.8% annually, below the industry's 6.9%.American Banking and Market NewsCytek Biosciences (NASDAQ:CTKB) Upgraded at Wall Street ZenWall Street Zen upgraded Cytek Biosciences from hold to buy, while Morgan Stanley and Stephens set price targets. The company reported Q3 EPS of -$0.05, beating estimates of -$0.07, with revenue of $53.23 million. Analysts expect -$0.36 EPS for the current year.TradingViewCytek Biosciences Q3 2026 Earnings Call Is LiveCytek Biosciences' Q3 2026 earnings call is live, with executives discussing financial results and answering analyst questions. The call may include surprise news, and management commentary on demand, margins, or capital spending could move markets.Business & FinancialCytek Biosciences To Participate In Upcoming Investor ConferencesCytek Biosciences will participate in two investor conferences: the UBS Global Healthcare Conference in Palm Beach Gardens on November 9, 2026, and the Stephens Annual Investment Conference in Nashville on November 17, 2026. The company's CFO and CEO will attend, with a fireside chat scheduled for the Stephens event.MarketBeatCytek Biosciences (CTKB) Set to Post Quarterly Earnings on WednesdayCytek Biosciences is expected to report Q3 2026 earnings after market close on November 4th, with analysts projecting a loss of $0.07 per share and revenue of $53.05 million. The company previously reported a loss of $0.09 per share and revenue of $48.14 million for the prior quarter. Analysts have an average 'Hold' rating with a consensus price target of $5.88.YahooGlobal Flow Cytometry Market Report 2026 | Capitalize on 11.3% CAGR as Beckman Coulter, Thermo Fisher, Cytek, and Bio-Rad Scale AI Automation and Precision MedicineThe global flow cytometry market is projected to grow from $7.49 billion in 2025 to $8.34 billion in 2026, a 11.3% CAGR, reaching $12.79 billion by 2030. Growth is driven by AI analytics, precision medicine, and HIV diagnosis demand. North America led the market in 2025.American Banking and Market NewsCytek Biosciences, Inc. (NASDAQ:CTKB) Stock Now Rated “Hold” by Wall Street AnalystsCytek Biosciences shares received an average "Hold" rating from six analysts, with a $5.56 price target. The company reported Q2 EPS of -$0.09, meeting estimates, and revenue of $48.14 million. Analysts expect a fiscal-year EPS of -$0.30.MarketBeatCytek Biosciences, Inc. (NASDAQ:CTKB) Stock Has Average Target Price of $5.56Cytek Biosciences shares have an average analyst target price of $5.56 with a Hold rating from six analysts. The stock opened at $5.31, and the company reported Q2 EPS of -$0.09, matching consensus, with revenue of $48.14 million. Analysts predict a fiscal-year EPS of -$0.30.RdworldonlineFlow cytometer fleets are aging. A new spectral sorter runs around $550,000 to $765,000Flow cytometer fleets are aging, with average analyzers 9 years old and sorters 8.5 years old. Spectral sorters cost $550,000 to $765,000, while conventional sorters cost $410,000 to $536,000. Labs are replacing filter-based sorters with spectral ones, and new models have been launched since 2024.